Literature DB >> 30396953

The Contribution of Interleukin-12 Genetic Variations to Taiwanese Lung Cancer.

Meng-Feng Wu1,2,3, Yun-Chi Wang1, Hsin-Ting Li1,4, Wei-Chun Chen1,5,6, Cheng-Hsi Liao1, Tzu-Ching Shih4, Wen-Shin Chang1, Chia-Wen Tsai7, Te-Chun Hsia7,5,6, DA-Tian Bau7,8,9.   

Abstract

BACKGROUND/AIM: Lung cancer is the leading cause of cancer-related death and a better marker for advanced personalized therapeutic approaches, such as immunotherapies, is in urgent need. Interleukin-12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects, however, the contribution of IL-12 genotypes to lung cancer is still largely unrevealed. The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in IL-12A and IL-12B are associated with lung cancer in a Taiwanese population.
MATERIALS AND METHODS: Genotypes of 358 lung cancer patients and 716 controls were determined by the polymerase chain reaction-restriction fragment length polymorphism method.
RESULTS: The distributions of genotypic (p=0.0036) and allelic (p=0.0005) frequencies of IL-12A rs568408 demonstrated significant differences between cases and controls. In detail, the AA genotype of IL-12A rs568408 was associated with a significantly elevated risk of lung cancer compared with the GG genotype (odds ratio(OR)=2.41, 95% confidence interval(CI)=1.36-4.29, p=0.0021). No difference was observed regarding IL-12A rs2243115 and IL-12B rs3212227 genotypes between the case and control groups. In addition, the results of interaction analysis showed that the AA genotype of IL-12A rs568408 was associated with elevated lung cancer risk, especially among those with smoking habits (p=0.0043).
CONCLUSION: IL-12A rs568404 AA genotype may contribute to the etiology and serve as a genomic determinant of lung cancer in Taiwanese, especially smokers. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Genotype; Taiwan; interleukin-12; lung cancer; single nucleotide polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30396953     DOI: 10.21873/anticanres.12989

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.

Authors:  Yu-Chao Lin; Wen-Shin Chang; Te-Chun Shen; Hsin-Ting Li; Chia-Hsiang Li; Yu-Chen Hsiau; Yun-Chi Wang; Cheng-Nan Wu; Chi-Li Gong; Zhi-Hong Wang; Chia-Wen Tsai; Te-Chun Hsia; DA-Tian Bau
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk.

Authors:  Li-Hsiou Chen; Te-Chun Shen; Chia-Hsiang Li; Kuo-Liang Chiu; Yu-Chen Hsiau; Yun-Chi Wang; Chi-Li Gong; Zhi-Hong Wang; Wen-Shin Chang; Chia-Wen Tsai; Te-Chun Hsia; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

3.  High Expression of Interleukin-12A and Its Association with the Clinicopathology and Prognosis of Differentiated Thyroid Cancer.

Authors:  Guo-Qiang Zhang; Chen-Tian Shen; Hong-Jun Song; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Eur Thyroid J       Date:  2020-04-17

4.  Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer.

Authors:  Te-Chun Shen; Wen-Shin Chang; Te-Chun Hsia; Chia-Wen Tsai; Da-Tian Bau; Hsin-Ting Li; Wei-Chun Chen
Journal:  Onco Targets Ther       Date:  2019-08-09       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.